Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of warts, specifically targeting common warts, which are characterized by their rough, 'cauliflower-like' surface appearance. It is also effective in safely removing plantar warts.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. For optimal results, the corn may be soaked in warm water for approximately 5 minutes to soften the tissue. After soaking, it is essential to dry the area completely.

If necessary, the medicated disc can be cut to fit the size of the wart. The medicated disc should then be carefully applied with the sticky side facing the wart. Following this, the center of a bandage strip should be placed over the medicated disc to secure it in position.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

• Patients with diabetes, due to potential complications related to blood sugar management.

• Individuals with poor blood circulation, as this may exacerbate underlying conditions.

• Application on irritated skin or any area that is infected or reddened is contraindicated to prevent further irritation or infection.

• The product should not be used on genital warts or warts located on the face, as these areas may require specialized treatment.

• Use is contraindicated on moles, birthmarks, and warts with hair growing from them to avoid potential adverse effects.

• Application on mucous membranes, including the nose, anus, genitals, and lips, is contraindicated due to the sensitivity of these areas.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with diabetes or poor blood circulation. It should not be applied to irritated skin or any area that is infected or reddened. Additionally, the product must not be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. It is also contraindicated for application on mucous membranes, including the nose, anus, genitals, and lips.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware that the product is for external use only. It is contraindicated in individuals with diabetes, poor blood circulation, or those with irritated skin or any area that is infected or reddened. Additionally, the product should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. It is also not intended for use on mucous membranes, including the nose, anus, genitals, and lips.

In the event that discomfort persists after application, patients are advised to discontinue use and consult a healthcare professional. Furthermore, it is crucial to keep the product out of reach of children. If ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (medicated wart removers). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that this medication should not be used by individuals with diabetes or those who have poor blood circulation. Additionally, patients should be cautioned against using the medication on irritated skin or any areas that are infected or reddened.

Patients must be made aware that the medication is not intended for use on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Furthermore, it should not be applied to mucous membranes, including the nose, anus, genitals, and lips.

Healthcare providers should instruct patients to discontinue use and consult a doctor if discomfort persists.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59° to 86°F (15° to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable environment to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)